Eyenovia Inc • EYEN

Capital at risk.

About Eyenovia Inc
Ticker
info
EYEN
Trading on
info
NASDAQ
ISIN
info
US30234E1047
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Michael M. Rowe
Headquarters
info
295 Madison Avenue, New York, NY, United States, 10017
Employees
info
13
Website
info
eyenovia.com
Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.
Metrics
BasicAdvanced
Market cap
info
$80.8M
P/E ratio
info
-
EPS
info
-$42.65
Dividend Yield
info
0.00%
Beta
info
1
Forward P/E ratio
info
0
EBIDTA
info
$-29.1M
Ex dividend date
info
-
Price & volume
Market cap
info
$80.8M
Average daily volume
info
-
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
1,204.11
Price to book
info
36.17
Earnings
EPS
info
-$42.65
EPS estimate (current quarter)
info
-$8.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-29.1M
Revenues (TTM)
info
$0.1M
Revenues per share (TTM)
info
$0.05
Technicals
Beta
info
1
52-week High
info
$41.06
52-week Low
info
$0.85
50-day moving average
info
$5.46
200-day moving average
info
$9.24
Short ratio
info
0.02
Short %
info
3.98%
Management effectiveness
ROE (TTM)
info
-388.03%
ROA (TTM)
info
-117.74%
Profit margin
info
0.00%
Gross profit margin
info
$-6.5M
Operating margin
info
-20,588.95%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
194.80%
Share stats
Outstanding Shares
info
5.1M
Float
info
2.6M
Insiders %
info
0.42%
Institutions %
info
13.39%
Analyst Insights & forecasts
info

0% Buy

100% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$2.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.21
-$0.15
-40.00%
Q2 • 24Missed
-$0.11
-$0.13
15.38%
Q3 • 24Beat
-$16.44
-$0.09
-18,166.67%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-20M
-71,031.15%
Q4 • 24
$0M
$-3.5M
-23,665.31%
Q1 • 25
-47.60%
-82.54%
-66.68%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$3.7M
$16.8M
457.06%
Q4 • 24
$6M
$15.7M
262.33%
Q1 • 25
63.15%
-6.36%
-42.60%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-6.1M
$-0M
$1M
$-6.1M
Q4 • 24
$-4.4M
$0M
$6.3M
$-4.4M
Q1 • 25
-27.30%
-100.00%
499.13%
-27.30%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Eyenovia Inc share?
Collapse

Eyenovia Inc shares are currently traded for undefined per share.

How many shares does Eyenovia Inc have?
Collapse

Eyenovia Inc currently has 5.1M shares.

Does Eyenovia Inc pay dividends?
Collapse

No, Eyenovia Inc doesn't pay dividends.

What is Eyenovia Inc 52 week high?
Collapse

Eyenovia Inc 52 week high is $41.06.

What is Eyenovia Inc 52 week low?
Collapse

Eyenovia Inc 52 week low is $0.85.

What is the 200-day moving average of Eyenovia Inc?
Collapse

Eyenovia Inc 200-day moving average is $9.24.

Who is Eyenovia Inc CEO?
Collapse

The CEO of Eyenovia Inc is Michael M. Rowe.

How many employees Eyenovia Inc has?
Collapse

Eyenovia Inc has 13 employees.

What is the market cap of Eyenovia Inc?
Collapse

The market cap of Eyenovia Inc is $80.8M.

What is the P/E of Eyenovia Inc?
Collapse

The current P/E of Eyenovia Inc is null.

What is the EPS of Eyenovia Inc?
Collapse

The EPS of Eyenovia Inc is -$42.65.

What is the PEG Ratio of Eyenovia Inc?
Collapse

The PEG Ratio of Eyenovia Inc is null.

What do analysts say about Eyenovia Inc?
Collapse

According to the analysts Eyenovia Inc is considered a hold.